Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 6, 2002, Pages 1205-1211

  Majetschak, Matthias ^a   Obertacke, Udo ^a   Schade, F Ulrich ^a   Bardenheuer, Mark ^a   Voggenreiter, Gregor ^a   Bloemeke, Brunhilde ^a   Heesen, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLUNT TRAUMA; CRITICAL ILLNESS; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INJURY SCALE; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEPSIS;

ADULT; ALLELES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS, NONPENETRATING;

EID: 0036843337     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.6.1205-1211.2002     Document Type: Article

References (43)

1. Abraham, L. J., and K. M. Kroeger. 1999. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease. J. Leukoc. Biol. 66:562-566.
2. American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-875.
3. Beutler, B., and A. Cerami. 1987. Cachectin: More than a tumor necrosis factor. N. Engl. J. Med. 316:379-385.
4. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:S423-435.
5. Bouma, G., J. B. Crusius, M. Oudkerk Pool, J. J. Kolkman, B. M. von Blomberg, P. J. Kostense, M. J. Giphart, G. M. Schreuder, S. G. Meuwissen, and A. S. Pena. 1996. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43:456-463.
6. Brinkman, B. M., D. Zuijdeest, E. L. Kaijzei, F. C. Breedveld, and C. L. Verweij. 1996. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J. Inflamm. 46:32-41.
7. Cabrera, M., M. A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit, and J. M. Blackwell. 1995. Polymorphism in tumor necrosis factor genes associated with mucocutanous leishmaniasis. J. Exp. Med. 182:1259-1264.
8. Ertel, W., J.-P. Kremer, J. Kenney, U. Steckholzer, D. Jarrar, O. Trentz, and F. W. Schildberg. 1995. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347.
9. Flach, R., M. Majetschak, T. Heukamp, V. Jennissen, S. Flohè, J. Börgermann, U. Obertacke, and F. U. Schade. 1999. Relation of ex vivo stimulated blood cytokine synthesis to posttraumatic sepsis. Cytokine 11:173-178.
10. Fugger, L., N. Morling, P. Ryder, J. Georgsen, B. K. Jakobsen, A. Svejgaard, V. Andersen, P. Oxholm, F. Karup Pedersen, and J. Friis. 1989. Nco1 restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in four autoimmune diseases. Tissue Antigens 34:17-22.
11. Greenspan, L., B. A. McLellan, and H. Greig. 1985. Abbreviated injury scale and injury severity score: A scoring chart. J. Trauma 25:60-64.
12. Hamann, A., C. Mantzoros, A. Vidal-Puig, and J. S. Flier. 1995. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem. Biophys. Res. Commun. 211:833-839.
13. Haskill, S., C. Hohnson, D. Eierman, S. Becker, and K. Warren. 1988. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J. Immunol. 140:1690-1694.
14. Heesen, M., U. Obertacke, F. U. Schade, B. Bloemeke, and M. Majetschak. 2002. The interleukin-6 (IL-6) G(-174)C polymorphism and the ex vivo IL-6 response to endotoxin in severely injured blunt trauma patients. Eur. Cytokine Netw. 13:72-77.
15. Kroeger, K. M., K. S. Carville, and L. J. Abraham. 1997. The -308 tumor necrosis factor α promotor polymorphism effects transcription. Mol. Immunol. 34:391-399.
16. Laitinen, T., M. L. Lokki, J. Partanen, M. Tulppala, O. Ylikorkala, and S. Koskimies. 1992. Tumor necrosis β gene polymorphism in relation to complotype in couples with spontaneous abortions and in control families. Scand. J. Immunol. 35:131-135.
17. Louis, E., D. Franchimont, A. Piron, Y. Gevaert, N. Schaaf-Lafontaine, S. Roland, P. Mahieu, M. Malaise, D. de Groote, R. Louis, and J. Belaiche. 1998. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113:401-406.
18. Majetschak, M., J. Börgermann, C. Waydhas, U. Obertacke, D. Nast-Kolb, and F. U. Schade. 2000. Diminished endotoxin induced whole blood TNF-α production and its relation to systemic concentrations of interleukin-4, interleukin-10 and transforming growth factor-β1 in multiply injured patients. Crit. Care Med. 28:1847-1854.
19. Majetschak, M., R. Flach, T. Heukamp, V. Jennissen, U. Obertacke, F. Neudeck, K. P. Schmit-Neuerburg, and F. U. Schade. 1997. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J. Trauma 43:880-887.
20. Majetschak, M., S. Flohé, U. Obertacke, J. Schröder, K. Staubach, D. Nast-Kolb, F. U. Schade, and F. Stüber. 1999. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann. Surg. 230:207-214.
21. Mantel, N., and W. Haenszel. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Institute 22:719-748.
22. McGuire, W., A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-α promotor region associated with susceptibility to cerebral malaria. Nature 371:508-511.
23. Messer, G., U. Spengler, M. C. Jung, G. Honold, K. Blomer, G. R. Pape, G. Riethmüller, and E. H. Weiss. 1991. Polymorphic structure of the tumor necrosis factor (TNF) locus: An Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173:209-219.
24. Mira, J. P., A. Cariou, F. Grall, C. Delclaux, M. R. Losser, F. Heshmati, C. Cheval, M. Monchi, J. L. Teboul, F. Riche, G. Leleu, L. Arbibe, A. Mignon, M. Delpech, and F. Dhainaut. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA 282:561-568.
25. Molving, J., F. Pociot, L. Baek, H. Worsaae, L. Dall Wogensen, P. Christensen, L. Staub-Nielsen, T. Mandrup-Poulsen, K. Manogue, and J. Nerup. 1990. Monocyte function in IDDM patients and healthy individuals. Scand. J. Immunol. 31:297-306.
26. Moos, V., M. Rudwaleit, V. Herzog, K. Hohlig, J. Sieper, and B. Müller. 2000. Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. Arthritis Rheum. 43:2417-2422.
27. Pauli, U. 1994. Control of tumor necrosis factor gene expression. Crit. Rev. Eukaryot. Gene Expr. 4:323-344.
28. Peruccio, D., S. d'Alfonso, I. Borelli, A. Amoroso, G. Mazzola, D. Marsico, M. Bersanti, and P. Richiardi. 1993. Distribution of tumor necrosis factor alleles (Nco1 RFLP) and their relationship to HLA haplotypes in an Italian population. Hum. Hered. 43:103-110.
29. Pociot, F., C. Briant, V. Jongeneel, J. Molvig, H. Worsaae, M. Abbal, M. Thomsen, J. Nerup, and A. Cambon-Thomsen. 1993. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:224-231.
30. Pociot, F., J. Molvig, L. Wogensen, H. Worsaae, H. Dalboge, L. Baek, and J. Nerup. 1991. A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33:37-49.
31. Pociot, F., S. D'Alfonso, S. Compasso, R. Scorza, and P. M. Richiardi. 1995. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand. J. Immunol. 42:501-504.
32. Rinasco, J., Y. Beraun, A. Nieto, A. Fraile, L. Mataran, E. Pareja, and J. Martin. 1997. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49:74-78.
33. Ruuls, S. R., and J. D. Sedgwick. 1999. Unlinking tumor necrosis factor biology from the major histocompatibility complex: Lessons from human genetics and animal models. Am. J. Hum. Genet. 65:294-301.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed., p. 14-21. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Strieter, R. N., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor alpha in disease states and inflammation. Crit. Care Med. 21:S447-463.
36. Stüber, F., I. A. Udalova, M. Book, L. N. Drutskaya, D. V. Kuprash, R. L. Turetskaya, F. U. Schade, and S. A. Nedospasov. 1996. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflamm. 46:42-50.
37. Stüber, F., M. Petersen, F. Bokelmann, and F. U. Schade. 1996. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24:381-384.
38. Tang, G. J., S. L. Huang, H. W. Yien, W. S. Chen, C. W. Chi, C. W. Wu, W. Y. Lui, J. H. Chiu, and T. Y. Lee. 2000. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit. Care Med. 28:2733-2736.
39. Trowsdale, J. 1993. Genomic structure and function in the MHC. Trends Genet. 9:117-122.
40. Warzocha, K., P. Ribeiro, J. Bienvenu, P. Roy, C. Charlot, D. Rigal, B. Coiffier, and G. Salles. 1998. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91:3574-3581.
41. Waterer, G. W., M. W. Quasney, R. M. Cantor, and R. G. Wunderink. 2001. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am. J. Respir. Crit. Care Med. 163:1599-1604.
42. Westendorp, R. G. J., J. A. M. Langermans, T. W. J. Huizinga, C. L. Verweij, and A. Sturk. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173.
43. Wilson, A. G., J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94:3195-3199.